Australia: Anteris raises A$35m with equity fundraising

Anteris Technologies, a structural heart company developing the world’s only balloon-expandable, 3D single-piece biomimetic aortic valve (DurAVR), has completed a A$35m (US$24m) equity fundraising. The company has issued 1.458 million new ordinary shares to at an issue price of A$24.00 per new share, The company’s two largest share-holders Perceptive Advisors and L1 Capital corner-stoned the…

You must be a HMI Subscriber to view this content.

Subscribe Now »